Oral and systemic health correlates of HIV-1 shedding in saliva

Journal of Dental Research

Volumn 89, Issue 10, 2010, Pages 1074-1079

  Navazesh, M ^a   Mulligan, R ^a   Kono, N ^b   Kumar, S K S ^a   Nowicki, M ^b   Alves, M ^c   MacK, W J ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

HIV 1 shedding; oral health; saliva

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADDICTION; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; GENETICS; GINGIVA BLEEDING; HEALTH; HEALTH STATUS; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; LONGITUDINAL STUDY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTICS; PHYSIOLOGY; SALIVA; SECRETION; TOOTH PLAQUE; VIROLOGY; VIRUS SHEDDING;

ADULT; ALCOHOL DRINKING; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DENTAL PLAQUE INDEX; DIABETES MELLITUS, TYPE 2; DMF INDEX; FEMALE; FOLLOW-UP STUDIES; GINGIVAL HEMORRHAGE; HEALTH STATUS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MIDDLE AGED; ORAL HEALTH; PERIODONTAL INDEX; RNA, VIRAL; SALIVA; SECRETORY RATE; SUBSTANCE-RELATED DISORDERS; VIRUS SHEDDING;

EID: 78049448226     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510375290     Document Type: Article

References (31)

1. Alves M., Mulligan R., Passaro D., Gawell S., Navazesh M., Phelan J., et al. (2006). Longitudinal evaluation of loss of attachment in HIV-infected women compared to HIV-uninfected women. J Periodontol 77: 773-779.
2. Barkan SE, Melnick SL, Preston-Martin S., Weber K., Kalish LA, Miotti P., et al. (1998). The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 9: 117-125.
3. Baron S., Poast J., Cloyd MW (1999). Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med 159: 303-310.
4. Barr CE, Miller LK, Lopez MR, Croxson TS, Schwartz SA, Denman H., et al. (1992). Recovery of infectious HIV-1 from whole saliva. J Am Dent Assoc 123: 36-37, 39-48.
5. Barr CE, Qureshi MN, Qiu Z., Kaim J., Zhang W. (1996). Oral HIV-I recovery in the presence of periodontal disease. Oral Dis 2: 198-201.
6. Campo J., Perea MA, del Romero J., Cano J., Hernando V., Bascones A. (2006). Oral transmission of HIV, reality or fiction? An update. Oral Dis 12: 219-228.
7. Cohen MS, Hellmann N., Levy JA, DeCock K., Lange J. (2008). The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest 118: 1244-1254.
8. Freel SA, Fiscus SA, Pilcher CD, Menezes P., Giner J., Patrick E., et al. (2003). Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. AIDS 17: 2025-2033.
9. Gandhi M., Koelle DM, Ameli N., Bacchetti P., Greenspan JS, Navazesh M., et al. (2004). Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res 83: 639-643.
10. Greenspan D., Komaroff E., Redford M., Phelan JA, Navazesh M., Alves ME, et al. (2000). Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS). J Acquir Immune Defic Syndr 25: 44-50.
11. Greenspan D., Gange SJ, Phelan JA, Navazesh M., Alves ME, MacPhail LA, et al. (2004). Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res 83: 145-150.
12. Habte HH, Mall AS, de Beer C., Lotz ZE, Kahn D. (2006). The role of crude human saliva and purified salivary Muc5b and Muc7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay. Virol J 3: 99.
13. Hall HI, Song R., Rhodes P., Prejean J., An Q., Lee LM, et al. (2008). Estimation of HIV incidence in the United States. JAMA 300: 520-529.
14. Lin AL, Johnson DA, Stephan KT, Yeh CK (2004). Salivary secretory leukocyte protease inhibitor increases in HIV infection. J Oral Pathol Med 33: 410-416.
15. Liuzzi G., Chirianni A., Clementi M., Bagnarelli P., Valenza A., Cataldo PT, et al. (1996). Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 10: F51 - F56.
16. Maticic M., Poljak M., Kramar B., Tomazic J., Vidmar L., Zakotnik B., et al. (2000). Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease. J Dent Res 79: 1496-1501.
17. Mulligan R., Navazesh M., Komaroff E., Greenspan D., Redford M., Alves M., et al. (2000). Salivary gland disease in Human Immunodeficiency Virus-positive women from the WIHS Study. Women's Interagency HIV Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 702-709.
18. Mulligan R., Phelan JA, Brunelle J., Redford M., Pogoda JM, Nelson E., et al. (2004). Baseline characteristics of participants in the oral health component of the Women's Interagency HIV Study. Community Dent Oral Epidemiol 32: 86-98.
19. Navazesh M., Christensen CM (1982). A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 61: 1158-1162.
20. Navazesh M., Mulligan R., Komaroff E., Redford M., Greenspan D., Phelan J. (2000). The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women. J Dent Res 79: 1502-1507.
21. Navazesh M., Mulligan R., Barron Y., Redford M., Greenspan D., Alves M., et al. (2003). A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 693-698.
22. Navazesh M., Mulligan R., Karim R., Mack WJ, Ram S., Seirawan H., et al. (2009). Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS). Oral Dis 15: 52-60.
23. Nowicki MJ, Benning L., Bremer JW, Meyer WA 3rd, Hanson C., Brambilla D., et al. (2001). Longitudinal variability of Human Immunodeficiency Virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and Nuclisens assays in a large multicenter study. J Clin Microbiol 39: 3760-3763.
24. Phelan JA, Mulligan R., Nelson E., Brunelle J., Alves ME, Navazesh M., et al. (2004). Dental caries in HIV-seropositive women. J Dent Res 83: 869-873.
25. Schacker T., Collier AC, Hughes J., Shea T., Corey L. (1996). Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 125: 257-264.
26. Scully C., Porter S. (2000). HIV topic update: oro-genital transmission of HIV. Oral Dis 6: 92-98.
27. Shugars DC, Wahl SM (1998). The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 129: 851-858.
28. Shugars DC, Slade GD, Patton LL, Fiscus SA (2000). Oral and systemic factors associated with increased levels of Human Immunodeficiency Virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 432-440.
29. Shugars DC, Sweet SP, Malamud D., Kazmi SH, Page-Shafer K., Challacombe SJ (2002). Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis 8 (Suppl 2). 169-175.
30. Yavuzyilmaz E., Yumak O., Akdoganli T., Yamalik N., Özer N., Ersoy F., et al. (1996). The alterations of whole saliva constituents in patients with diabetes mellitus. Aust Dent J 41: 193-197.
31. Yeung SC, Kazazi F., Randle CG, Howard RC, Rizvi N., Downie JC, et al. (1993). Patients infected with Human Immunodeficiency Virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis 167: 803-809.